Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
SZSE:300760 주식 보고서
Shenzhen Mindray Bio-Medical Electronics 과거 수익 실적 Shenzhen Mindray Bio-Medical Electronics은 연평균 19.4%의 비율로 수입이 증가해 온 반면, Medical Equipment 산업은 수입이 증가했으며, 연간 6.1%였습니다. 매출은 연평균 17%의 비율로 증가했습니다. Shenzhen Mindray Bio-Medical Electronics의 자기자본이익률은 29.6%이고 순이익률은 33.4%입니다.
주요 정보 Medical Equipment 산업 성장 16.0% 매출 성장률 17.0% 자기자본 수익률 29.6% 순이익 33.4% 최근 수익 업데이트 30 Sep 2024
최근 과거 실적 업데이트
Third quarter 2024 earnings: EPS and revenues miss analyst expectations Oct 30
Shenzhen Mindray Bio-Medical Electronics Co., Ltd. to Report Q3, 2024 Results on Oct 30, 2024 Sep 30
Second quarter 2024 earnings: EPS and revenues exceed analyst expectations Aug 31
First quarter 2024 earnings: EPS exceeds analyst expectations while revenues lag behind Apr 27
Shenzhen Mindray Bio-Medical Electronics Co., Ltd. to Report Q1, 2024 Results on Apr 27, 2024 Mar 30
Shenzhen Mindray Bio-Medical Electronics Co., Ltd. to Report Fiscal Year 2023 Results on Apr 27, 2024 Dec 30
모든 업데이트 표시
Third quarter 2024 earnings: EPS and revenues miss analyst expectations Oct 30
Is There An Opportunity With Shenzhen Mindray Bio-Medical Electronics Co., Ltd.'s (SZSE:300760) 27% Undervaluation? Oct 24
Investor sentiment deteriorates as stock falls 17% Oct 15
Now 24% undervalued after recent price drop Oct 15
Shenzhen Mindray Bio-Medical Electronics (SZSE:300760) Ticks All The Boxes When It Comes To Earnings Growth Oct 08
Shenzhen Mindray Bio-Medical Electronics Co., Ltd. to Report Q3, 2024 Results on Oct 30, 2024 Sep 30
Investor sentiment improves as stock rises 16% Sep 27
Second quarter 2024 earnings: EPS and revenues exceed analyst expectations Aug 31
Shenzhen Mindray Bio-Medical Electronics Co., Ltd. Proposes Interim Dividend for the First Half of 2024 Aug 31
Risks To Shareholder Returns Are Elevated At These Prices For Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (SZSE:300760) Aug 12
Shareholders Would Enjoy A Repeat Of Shenzhen Mindray Bio-Medical Electronics' (SZSE:300760) Recent Growth In Returns Jul 28
Estimating The Fair Value Of Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (SZSE:300760) Jun 06
Now 21% undervalued May 31
Dividend of CN¥1.50 announced May 23
These 4 Measures Indicate That Shenzhen Mindray Bio-Medical Electronics (SZSE:300760) Is Using Debt Safely May 21
Analysts Have Made A Financial Statement On Shenzhen Mindray Bio-Medical Electronics Co., Ltd.'s (SZSE:300760) First-Quarter Report Apr 30
Shenzhen Mindray Bio-Medical Electronics Co., Ltd., Annual General Meeting, May 17, 2024 Apr 29
Shenzhen Mindray Bio-Medical Electronics Co., Ltd., Annual General Meeting, May 17, 2024 Apr 28
First quarter 2024 earnings: EPS exceeds analyst expectations while revenues lag behind Apr 27
Shenzhen Mindray Bio-Medical Electronics Co., Ltd.'s (SZSE:300760) Share Price Not Quite Adding Up Apr 21
Shenzhen Mindray Bio-Medical Electronics (SZSE:300760) Looks To Prolong Its Impressive Returns Apr 02
Shenzhen Mindray Bio-Medical Electronics Co., Ltd. to Report Q1, 2024 Results on Apr 27, 2024 Mar 30
Now 20% undervalued after recent price drop Jan 29
Now 20% undervalued Jan 17
Shenzhen Mindray Bio-Medical Electronics Co., Ltd. to Report Fiscal Year 2023 Results on Apr 27, 2024 Dec 30
Shenzhen Mindray Bio-Medical Electronics Co., Ltd. Implements Profit Distribution for Third Quarter of 2023, Payable on 22 November 2023 Nov 17
Shenzhen Mindray Bio-Medical Electronics Co., Ltd. Approves Profit Distribution Plan for Third Quarter 2023 Nov 15 Shenzhen Mindray Bio-Medical Electronics Co., Ltd. Proposes Third Quarterly Dividend Oct 31
Third quarter 2023 earnings: EPS and revenues exceed analyst expectations Oct 29
Shenzhen Mindray Bio-Medical Electronics Co., Ltd. to Report Q3, 2023 Results on Oct 30, 2023 Sep 30
Price target decreased by 8.1% to CN¥402 Sep 08
Second quarter 2023 earnings: EPS exceeds analyst expectations Aug 30 Shenzhen Mindray Bio-Medical Electronics Co., Ltd. Approves Cash Dividend for 2022
Full year 2022 earnings released: EPS: CN¥7.94 (vs CN¥6.59 in FY 2021) Apr 28
Mindray Revolutionizes the Way of Using Ultrasound with TE Air, Its First Wireless Handheld Ultrasound System Feb 15
Mindray Introduces New Wearable Patient Monitoring System, Refining Clinician’s Workflow to Track Patient Conditions Dec 05
Less than half of directors are independent Nov 16
Third quarter 2022 earnings: EPS in line with expectations, revenues disappoint Oct 28
Investor sentiment improved over the past week Sep 30
Second quarter 2022 earnings: EPS exceeds analyst expectations Aug 21
Mindray Reimagines Point of Care Systems with Launch of New TEX20 Diagnostic Ultrasound Series At Euroanaesthesia 2022 Jun 15 Shenzhen Mindray Bio-Medical Electronics Co., Ltd. Announces 2021 Final Profit Distribution Plan to Be Implemented (A Shares), Payable on 19 May 2022
Less than half of directors are independent Apr 27
Shenzhen Mindray Bio-Medical Electronics Co., Ltd., Annual General Meeting, May 10, 2022 Apr 22
Shenzhen Mindray Bio-Medical Electronics Co., Ltd. Proposes Final Dividend for the Year 2021 Apr 21
First quarter 2022 earnings: EPS and revenues exceed analyst expectations Apr 21
Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (SZSE:300760) announces an Equity Buyback for CNY 1,000 million worth of its shares. Jan 14
Third quarter 2021 earnings released: EPS CN¥1.91 (vs CN¥1.57 in 3Q 2020) Oct 20
Mindray Launches New MC-80 Automated Digital Cell Morphology Analyzer, Taking Morphology Analysis to the Next Level Sep 29
Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (SZSE:300760) completed the acquisition of HyTest Ltd. from Summa Equity. Sep 24
Investor sentiment improved over the past week Sep 22
Mindray Announces the Launch of its Latest Point-Of-Care (POC) Ultrasound System, the TE9 Sep 11
Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (SZSE:300760) announces an Equity Buyback for CNY 1,000 million worth of its shares. Aug 27
Price target decreased to CN¥489 Aug 27
Second quarter 2021 earnings released: EPS CN¥2.16 (vs CN¥1.76 in 2Q 2020) Aug 26
Investor sentiment deteriorated over the past week Aug 20
Mindray Unveils Nuewa I9, A New Ob/GYN Diagnostic Ultrasound System Jun 09
Mindray Launches Resona I9 Ultrasound System, Revolutionizing General Imaging Jun 03
Mindray Defines Future of Imaging Technologies with New General Imaging, Women's Healthcare and Cardiology Ultrasound Solutions May 31
Shenzhen Mindray Bio-Medical Electronics Co., Ltd. Approves Cash Dividend for the Year 2020, Payable on 28 May 2021 May 22
Price target increased to CN¥502 May 04
First quarter 2021 earnings released: EPS CN¥1.41 (vs CN¥1.08 in 1Q 2020) May 01
Shenzhen Mindray Bio-Medical Electronics Co., Ltd. Proposes Final Dividend for the Year 2020 Apr 30
Price target increased to CN¥480 Apr 30
Investor sentiment deteriorated over the past week Mar 08
New 90-day high: CN¥492 Feb 09
Mindray Launches New BeneFusion e Series Infusion Systems, Delivering Efficiency in Every Droplet Feb 03
Mindray Transforms Spot Check Patient Monitoring with New VS Series Vital Signs Monitors Jan 28
New 90-day high: CN¥478 Jan 22
New 90-day high: CN¥418 Dec 30
Price target raised to CN¥412 Oct 31
Third quarter earnings released Oct 30
Annual earnings released: Earnings beat expectations Oct 30
New 90-day high: CN¥395 Oct 29
Mindray Brings New Systems to the High-End Anesthesia System Market Oct 16
Price target raised to CN¥406 Oct 16
New 90-day high: CN¥358 Oct 09
Price target raised to CN¥378 Sep 01
First half earnings released Aug 29
Shenzhen Mindray Bio-Medical Electronics Co., Ltd. to Report First Half, 2020 Results on Aug 28, 2020 Aug 13
Shenzhen Mindray Bio-Medical Electronics 수익 창출 및 지출 방식. 최근 보고된 수익 기준, LTM 기준.
수익 및 매출 내역 SZSE:300760 수익, 비용 및 수입 (CNY Millions ) 날짜 수익 수익 G+A 비용 R&D 비용 30 Sep 24 37,113 12,385 7,813 3,516 30 Jun 24 36,987 12,701 7,676 3,357 31 Mar 24 35,940 12,171 7,618 3,528 31 Dec 23 34,932 11,582 7,471 3,433 30 Sep 23 34,374 11,339 6,517 3,344 30 Jun 23 33,486 10,762 7,069 3,424 31 Mar 23 31,787 10,073 6,601 3,071 01 Jan 23 30,366 9,607 6,159 2,923 30 Sep 22 29,174 9,441 5,654 2,982 30 Jun 22 27,847 8,945 5,387 2,813 31 Mar 22 26,432 8,392 5,264 2,640 01 Jan 22 25,270 8,002 5,098 2,524 30 Sep 21 24,354 7,957 4,688 2,148 30 Jun 21 23,240 7,548 4,603 2,027 31 Mar 21 22,066 7,059 4,577 1,976 31 Dec 20 21,026 6,658 4,539 1,869 30 Sep 20 20,240 6,373 4,740 1,732 30 Jun 20 18,915 5,765 4,672 1,664 31 Mar 20 17,391 4,988 4,651 1,603 31 Dec 19 16,556 4,681 4,380 1,466 30 Sep 19 15,853 4,494 4,267 1,382 30 Jun 19 15,151 4,217 4,181 1,333 31 Mar 19 14,423 3,918 4,036 1,331 31 Dec 18 13,753 3,719 3,937 1,267 30 Sep 18 13,109 3,492 3,808 1,233 31 Dec 17 11,174 2,589 3,387 1,018 31 Dec 16 9,032 1,600 4,185 0 31 Dec 15 8,013 910 3,916 0 31 Dec 14 7,836 1,360 3,733 0
양질의 수익: 300760 은 높은 수익 을 보유하고 있습니다.
이익 마진 증가: 300760 의 현재 순이익 이익률 (33.4%) 작년보다 높습니다 (33%).
과거 수익 성장 분석
수익추이: 300760 의 수입은 지난 5년 동안 매년 19.4% 씩 증가했습니다.
성장 가속화: 지난 1년간 300760 의 수익 증가율( 9.2% )은 5년 평균( 19.4% 보다 낮습니다. 년도).
수익 대 산업: 지난 1년간 300760 수익 증가율( 9.2% )은 Medical Equipment 업계 -8.8% 초과했습니다.
자기자본 수익률
높은 ROE: 300760 의 자본 수익률 ( 29.6% )은 높음 으로 간주됩니다.
Simply Wall St™ Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.
{"enabled":true,"variant":{"name":"control","enabled":true,"feature_enabled":true,"featureEnabled":true},"flagsReady":true,"flagsError":null}
